Aplysia acetylcholine receptors: blockade by and binding of alpha-bungarotoxin. 1974

W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008688 Methacholine Compounds A group of compounds that are derivatives of beta-methylacetylcholine (methacholine). Compounds, Methacholine
D008974 Mollusca A phylum of the kingdom Metazoa. Mollusca have soft, unsegmented bodies with an anterior head, a dorsal visceral mass, and a ventral foot. Most are encased in a protective calcareous shell. It includes the classes GASTROPODA; BIVALVIA; CEPHALOPODA; Aplacophora; Scaphopoda; Polyplacophora; and Monoplacophora. Molluscs,Mollusks,Mollusc,Molluscas,Mollusk
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D002038 Bungarotoxins Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms. alpha-Bungarotoxin,beta-Bungarotoxin,kappa-Bungarotoxin,alpha Bungarotoxin,beta Bungarotoxin,kappa Bungarotoxin

Related Publications

W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
January 1981, Neuroscience,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
February 1976, Archives of ophthalmology (Chicago, Ill. : 1960),
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
January 1979, Journal of supramolecular structure,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
April 1995, Molecular pharmacology,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
January 1978, Neuroscience,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
January 1974, Methods in enzymology,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
September 1973, British journal of pharmacology,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
October 1974, Science (New York, N.Y.),
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
January 1993, Brain research. Molecular brain research,
W Shain, and L A Greene, and D O Carpenter, and A J Sytkowski, and Z Vogel
May 1989, Molecular pharmacology,
Copied contents to your clipboard!